Page last updated: 2024-09-03

u 99194a and 5-hydroxy-1-methyl-2--(di-n-propylamino)tetralin methyl ether

u 99194a has been researched along with 5-hydroxy-1-methyl-2--(di-n-propylamino)tetralin methyl ether in 1 studies

Compound Research Comparison

Studies
(u 99194a)
Trials
(u 99194a)
Recent Studies (post-2010)
(u 99194a)
Studies
(5-hydroxy-1-methyl-2--(di-n-propylamino)tetralin methyl ether)
Trials
(5-hydroxy-1-methyl-2--(di-n-propylamino)tetralin methyl ether)
Recent Studies (post-2010) (5-hydroxy-1-methyl-2--(di-n-propylamino)tetralin methyl ether)
620104210

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Annoh, N; Harano, M; Tanaka, M; Yamada, S1

Other Studies

1 other study(ies) available for u 99194a and 5-hydroxy-1-methyl-2--(di-n-propylamino)tetralin methyl ether

ArticleYear
Dopamine D(3) receptors modulate evoked dopamine release from slices of rat nucleus accumbens via muscarinic receptors, but not from the striatum.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 291, Issue:3

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Dopamine; Dopamine Agonists; Dopamine Antagonists; Electric Stimulation; Haloperidol; In Vitro Techniques; Indans; Male; Muscarinic Antagonists; Neostriatum; Nucleus Accumbens; Pirenzepine; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Muscarinic

1999